Clinically Proven Hair Growth Laser Device. FDA Cleared* for Men & Women.

Stimulating hair growth has never been easier or faster. The LaserBand 82 delivers therapeutic light energy directly to your hair follicles through 82 medical-grade lasers (No LEDs). The unique curved design incorporates patented hair parting teeth which part your hair during treatment to allow optimal laser light delivery to your follicles. A proprietary 3 part synergistic sytem – the hair parting teeth, the laser light intensity and the laser light density work in unison to provide a highly effective treatment for hair loss and thinning hair.

Comfortable, portable and convenient for home use or while traveling. Fast, Easy and Effective – treatment takes as little as 90 seconds, 3 days a week.

Now you can experience new hair growth with increased density and fullness with the LaserBand 82!

HairMax Laser devices FDA 510(k) Clearances as Medical Devices Are Based Not Only On Safety But Also On The Submission Of Proof of Efficacy.

There have now been a total of 7 FDA Clearances of HairMax Laser devices for marketing, all of which required the submission of not only safety, but also effectiveness based on scientifically designed clinical research studies.
These submissions and all of our FDA Clearances, means that all data submitted was subject to intense scrutiny and review. When a company receives FDA Clearance, there are stringent rules and high standards put into place covering all aspects of manufacturing and quality control.
To put it simply, we know there are countless products on the market that promise to re-grow hair, but end up having little or no effectiveness. You can trust HairMax to treat your hair loss, because of the extensive clinical research conducted which proves the efficacy and safety of HairMax devices. Our clinical studies results have been conducted by top physicians in the field of hair loss and study results have been published in 6 peer review medical journals, this makes HairMax the only laser devices for hair loss on the market with such unsurpassed substantial validation